Endochondral Ossification in Critical-Sized Bone Defects via Readily Implantable Scaffold-Free Stem Cell Constructs

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Orthopedic Tissue Engineering

Background:

• Musculoskeletal injuries pose a significant socioeconomic burden.
• Current therapies for bone defects have limitations.
• Tissue engineering offers a promising approach for functional tissue regeneration.

Purpose of the Study:

• To engineer a scaffold-free system for guided endochondral bone formation.
• To investigate the controlled delivery of transforming growth factor-beta 1 (TGF-β1) and bone morphogenetic protein-2 (BMP-2) for bone healing.
• To evaluate the efficacy of this system in a rat calvarial defect model.

Main Methods:

• Human bone marrow-derived mesenchymal stem cells were embedded with bioactive microparticles.
• Microparticles were designed for sequential release of TGF-β1 and BMP-2.
• Constructs were implanted into critical-sized rat calvarial defects and analyzed using micro-computed tomography and histology.

Main Results:

• Microparticle-incorporated constructs promoted greater bone formation compared to controls.
• Constructs loaded with both BMP-2 and TGF-β1 achieved the greatest bone healing and bony bridging.
• Bone volume fraction significantly increased from 4 to 8 weeks with dual growth factor treatment.
• Evidence of endochondral ossification and angiogenesis was observed.

Conclusions:

• The engineered scaffold-free system effectively guides endochondral bone formation.
• This system offers a readily implantable, combination therapy for accelerated bone healing.
• It bypasses the need for lengthy in vitro cell priming, enhancing translational potential.